Cardiology Journal · 2026
Clinical characteristics of outpatients with HFpEF and HFmrEF at a cardiology clinic in Poland: a 2025 cross-sectional study
By Szychta W, Filipiak KJ
INTRODUCTION: Chronic heart failure is a highly prevalent condition in aging populations. In Poland, it is estimated to affect approximately 1.2 million individuals, with a substantial number of cases being misdiagnosed, partly due to the presence of comorbidities. This cross-sectional, single-center study aimed to collect real-world data on ambulatory patients diagnosed with either heart failure with mildly reduced ejection fraction (HFmrEF) or preserved ejection fraction (HFpEF). MATERIAL AND METHODS: Patients were screened for eligibility during routine outpatient visits using an integrated diagnostic pathway consistent with the Heart Failure Association's HFA-PEFF algorithm. Data included patient demographics, clinical characteristics, cardiovascular parameters, comorbidities, and pharmacotherapy. RESULTS: A total of 500 patients were included; nearly 70% were women. HFpEF was diagnosed in 75.6% of patients, whereas HFmrEF was identified in 24.4%. Most patients had hypertension (84.8%) and peripheral arterial disease (77.4%); and 23.8% of patients had type 2 diabetes. The mean left atrial volume index (LAVI) was 44.9 ± 19.1 mL/m2, and the mean E/e' ratio was 13.8 ± 5.4. Reduced renal function (eGFR < 60 mL/min/1.73 m2) was observed in 42% of patients. All participants received combination pharmacotherapy, most commonly finerenone (98.8%), beta-blockers (82.8%), and sodium-glucose cotransporter 2 inhibitors (SGLT2is) (98.6%); over half of all participants (59.8%) were treated with loop diuretics. CONCLUSIONS: The study provides valuable real-world data on patients with chronic heart failure at a single outpatient cardiology clinic in Poland, highlighting a predominance of the HFpEF phenotype, which is consistent with recent trends in heart failure diagnosis.